Aktis Oncology - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeAktis Oncology
Aktis Oncology logo

Aktis Oncology

0 followers

About Aktis Oncology

Aktis Oncology is a biotechnology company focused on transforming cancer care with novel platform technologies that enable the design and development of precision radiopharmaceuticals. These targeted therapies harness the potent anticancer effects of alpha-emitting particles. The company is pursuing a broad set of targets in commonly occurring cancers to create radiopharmaceuticals that could provide treatment options where currently limited therapies exist.

Recent News

Recent Deals

Key Team Members

Akos Czibere

Chief Medical Officer

Paul Feldman

Chief Scientific Officer

Yuan Xue

VP, Regulatory Affairs

Karen Mccarthy

Vice President, Head Of Finance

Key Facts

HQ Location

Boston, United States

Founded

2020

Employees

51 - 200

Status

Private

Website

https://aktisoncology.com